Quick Answer
Jazz Pharmaceuticals plc reported Total Assets of $11.66 billion for fiscal year 2025.
Jazz Pharmaceuticals plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $11.66B | -2.9% |
| 2024 | $12.01B | +5.4% |
| 2023 | $11.39B | +5.2% |
| 2022 | $10.84B | -11.9% |
| 2021 | $12.30B | +88.2% |
| 2020 | $6.54B | +18.0% |
| 2019 | $5.54B | +6.4% |
| 2018 | $5.20B | +1.6% |
| 2017 | $5.12B | +6.7% |
| 2016 | $4.80B | +44.0% |
| 2015 | $3.33B | -0.2% |
| 2014 | $3.34B | +49.2% |
| 2013 | $2.24B | +13.8% |
| 2012 | $1.97B | +675.5% |
| 2011 | $253.57M | +86.8% |
| 2010 | $135.73M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.36B | -7.3% | +3.8% |
| June 30, 2025 | $10.94B | -3.7% | -5.1% |
| March 31, 2025 | $11.53B | +1.8% | -4.0% |
| December 31, 2024 | $12.01B | +5.4% | -2.0% |
| September 30, 2024 | $12.26B | +9.4% | +7.9% |
| June 30, 2024 | $11.36B | +0.9% | +0.3% |
| March 31, 2024 | $11.33B | +2.5% | -0.6% |
| December 31, 2023 | $11.39B | +5.2% | +1.7% |
- Jazz Pharmaceuticals plc showed a decrease of -2.9% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Jazz Pharmaceuticals plc’s total assets has grown by 8490.2% (from $135.73 million to $11.66 billion).
- The most recent figure is from Jazz Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: